All News | FDA

Advertising & Promotion

Jan 27, 2021
Acting Director Wants OPDP To Be More Visible
Jan 22, 2021
Woodcock Becomes Acting FDA Commissioner Following Hahn’s Resignation as Biden Administration Begins
Jan 21, 2021
Journal Article Scrutinizes Nurse Ambassador Programs
Jan 11, 2021
N.Y. Assembly Bill Aims To Keep Individual Prescribing Data Confidential
Jan 6, 2021
FDA Debars Three Former Insys Executives
Dec 29, 2020
Senate Report Calls for Adding Payments to Tax-exempt Groups to Open Payments Database
Dec 21, 2020
Drug Company and Specialty Pharmacy Settle False Claims Act Case Over Payments to Foundations
Dec 16, 2020
OPDP Researchers Move Ahead with Endorsement Studies, Report on Completed Research
Dec 4, 2020
OPDP Issues Second Untitled Letter of 2020
Dec 2, 2020
Companies Settle FCA Case Over Improper Promotion of Drug-Device Combo Product for Pediatric Use

Good Clinical Practice

Mar 3, 2021
Questions Over Investigational Drug, Informed Consent Result in Warning Letter
Feb 24, 2021
Illinois Bill Calls for Medicaid Coverage of Routine Care Costs in Clinical Trials
Feb 17, 2021
Clinical Investigator Receives Warning Letter for Not Following Trial’s Investigational Plan
Feb 11, 2021
Senators: FDA Should Investigate Inaccuracies in Oximeter Blood Oxygen Readings Among Persons of Color
Feb 6, 2021
CTTI Issues COVID-19 Clinical Trial Playbook
Feb 2, 2021
FDA Issues Guidance on Conducting BE Studies During COVID Pandemic
Jan 28, 2021
Group Provides Recommendations for Inclusion of Pregnant Women in Vaccine Research
Jan 22, 2021
Woodcock Becomes Acting FDA Commissioner Following Hahn’s Resignation as Biden Administration Begins
Jan 19, 2021
FCC: Recorded Phone Trial Recruitment Pitches Are OK
Jan 12, 2021
Investigator Pleads Guilty to Conspiring To Falsify Trial Data

U.S. Food Labeling

Jul 31,2019
FSIS Rejects Request to Require New Warning on Processed Meat, Poultry Labels
Jul 25,2019
Seafood VP Pleads Guilty to Conspiracy To Mislabel Millions of Dollars, Tons of Dollars of Crab
Jul 18,2019
Demands for FDA To Act on Plant-Based Labeling Continue Apace
Jul 11,2019
Oatly, Supplement Maker Back Away from Challenged Claims
Jul 11,2019
More Time Given for Feedback on Potassium Chloride in Food Labeling
Jul 11,2019
FSIS Provides Guidance on Kit Products
Jul 11,2019
Groups Sue To Stop Implementation of Mississippi 'Veggie' Law
Jul 3,2019
Following Trend, Court Holds That Calling Soda ‘Diet’ Does Not Promise Weight Loss
Jun 26,2019
FDA Gives Go-ahead to Use of Qualified Health Claims for EPA, DHA
Jun 20,2019
Guidance Issued for Labeling Single-Ingredient Honey, Syrup, Cranberries

FDA Regulation & Enforcement

May 15, 2024
DOJ Brings First Enforcement Action Involving Adulterated, Misbranded Weight Loss Drug Semaglutide
May 11, 2024
Bakeries Issued Warning Letters Alleging Labeling Violations
May 8, 2024
HHS OIG: Patient Assistance Charity Funded by Drug Companies Will Not Trigger Anti-Kickback Sanctions
May 6, 2024
Prominently Disclosing Study Rigor May Aid Promotional Claims
May 1, 2024
DOJ Launches Pilot Program Offering NPAs to Individuals Who Self-Disclose Criminal Conduct
Apr 26, 2024
FDA Issues Revised Guidance on Promotion of Biosimilars
Apr 24, 2024
Products Liability Suit Involving Recalled Implanted Defibrillator Implicated in Death Is Dismissed
Apr 23, 2024
Endo Health Solutions Pleads Guilty to Marketing Opioid as Abuse Deterrent Without Supporting Data
Apr 22, 2024
Bill To Require FOP Warning Labels Introduced in Senate
Apr 18, 2024
District Court Dismisses Labeling Case Against Dole Fruit Products

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.